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Abstracts / Osteoarthritis and Cartilage 22 (2014) S7–S56 S41CpG dinucleotides differs substantially between hips and knees, generic
OA related differential methylation was observed in both hips and
knees. Furthermore, we show that mere methylation differences do not
imply gene regulation and therefore do not per se elucidate epigenetic
regulatory properties of OA associated genes. Finally, gene set enrich-
ment revealed that in late-stage disease extracellular matrix remodel-
ling associated genes are still actively regulated epigenetically.
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NOVEL VARIANTS FOR CARTILAGE THICKNESS AND HIP
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Purpose: Hip osteoarthritis (HOA) is one of themost disabling diseases in
the elderly. It has a large genetic component estimated between 40-60%.
Heritability of hip joint spacenarrowing is estimated tobe around64%. To
date, genome-wide association studies (GWAS) in osteoarthritis (OA)
have yielded only few loci, which is partly explained by heterogeneity in
the phenotype used to deﬁne OA. Therefore, we have chosen to focus on
radiographically measured joint-space width (mJSW), a proxy for carti-
lage thickness and an important underlying intermediate trait for HOA.
Methods:We conducted a genome-wide association study of mJSW in a
discovery set of 13,013 participants from ﬁve different cohorts (Rot-
terdam Study I and II, TwinsUK, SOF and MrOS) using standardized age,
gender and population stratiﬁcation-adjusted residuals from linear
regression. We replicated signals with a P<5*10-6 in 6,168 individuals
from 6 independent cohorts: GARP, JoCo, Chingford, GOAL, GOGO and
CHECK. We combined results from all studies in a joined meta-analysis
using inverse variance weighting (METAL). We also tested for associa-
tion between mJSW genetic risk score and mJSW/HOA using logistic
regression.
Results: The discovery analysis (N¼13,013) yielded 18 genetic loci with
suggestive evidence for association (P<5*10-6). Six of the loci replicated
signiﬁcantly in the replication cohorts (N¼6,168). When we combined
discovery and replication results, ﬁve loci reached genome-wide sig-
niﬁcance (P<5x10-8), while another 2 loci had suggestive evidence
(P<5x10-7) for association. The analysis yielded 2 known HOA loci: 1)
SUPT3H and 2) DOT1L, and 5 novel loci. Three of these novel loci were
also signiﬁcantly associated with HOA (P<10-4) in a meta-analysis of 17
studies (n¼37,156): 1) TGFA, 2) RUNX2, and 3) FGFR3. FGFR3 and
RUNX2 encode proteins known to be involved in bone and cartilage
development. TGFA has been shown to be important in experimental
OA models in mice; this is the ﬁrst report linking TGFA to human OA.
We constructed a genetic risk score using the 7 identiﬁedmJSW loci and
examined association with mJSW and HOA. Within the Rotterdam
Study, we found that individuals carrying more than 7 risk alleles (21%
of the population) had 11% lower mJSW (P¼2*10-11), and a 3 times
higher risk for HOA (P¼1*10-3) compared to those individuals carrying
0-2 risk alleles.
Conclusions: We identiﬁed 3 novel loci (TGFA, RUNX2, and FGFR3) and
conﬁrmed 2 loci known to be associated with cartilage thickness and
HOA. Together, the identiﬁed loci for mJSW may be used to risk-stratify
individuals for HOA. Our ﬁndings provide insight into the genetics of
HOA, revealing that cartilage growth and bone developmental path-
ways may play an important role in the pathology of HOA and serve as
targets for future therapies.
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LOSS OF MITOGEN-INDUCIBLE GENE 6 RESULTS IN DISTURBED
CARTILAGE AND JOINT HOMEOSTASIS
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London, ON, Canada; zMichigan State Univ., Grand Rapids, MI, USAIntroduction: Osteoarthritis (OA) is a degenerative joint disease which
causes destruction of articular cartilage and altered morphology of the
supporting bone. Treatment of OA is currently limited to relief of pain
symptoms, and does not address the underlying cause. Previous studies
in our lab have shown that the cytokine transforming growth factor
alpha (TGFa) is upregulated both in a subset of human OA cases and in
animals models (Appleton et al., 2007;2010). TGFa binds and activates
epidermal growth factor receptor (EGFR) and signalling is attenuated by
mitogen-inducible gene 6 (Mig-6) which both blocks EGFR autophos-
phorylation and induces internalization. Whole body deletion of Mig-6
in mice has been shown to cause multiple phenotypes including the
rapid development of joint deformities and cartilage degeneration
(Zhang et al, 2005; Jin et al, 2007), however the tissue and cell types
involved have not yet been identiﬁed.
Purpose: To determine the role of Mig-6 and increased EGFR signalling
in cartilage degeneration and joint homeostasis through the targeted
deletion of Mig-6 in the cartilage of mice.
Methods: Mig-6 was selectively deleted in the cartilage of mice using
the Cre-Lox system, with ﬂoxedMig-6 (Mig-6ﬂ/ﬂ) and Cre driven by the
Col2a1 promoter (Col2-Creþ/-). Animals were kept on a normal diet
and activity levels were unregulated. Littermate controls were used in
all experiments. MicroCT at 20 and 50 mm/voxel resolutions was used to
assess changes in bone density and morphology at 12-36 weeks of age.
Alcian blue/alizarin red whole skeletal stains were used to examine
early skeletal morphology at 40 days of age (P40). Histological stains
including safranin O/fast green, picrosirius red, toluidine blue, tartrate
resistant acid phosphatase (TRAP) and immunohistochemistry (IHC)
were also used to further determine morphological and molecular
changes in cartilage and bone.
Results: The overall skeletal morphology and weights of cartilage
speciﬁc Mig-6 knockout mice (KO, Mig-6ﬂ/ﬂ;Col2-Creþ/-) were com-
parable to control animals (Mig-6ﬂ/ﬂ;Col2-Cre-/- or Mig-6ﬂ/þ;Col2-
Cre-/-). However, ectopic cartilage and calciﬁed tissues in the knees of
KO animals were observed at early time points (12 weeks) and later in
the spine as the animals aged (36 weeks). These tissues formed as
highly cellular partially calciﬁed cartilaginous growths at 12 weeks and
became progressively more bone-like by 36 weeks. IHC showed
increased SOX9 and phosphoEGFR (activated) in both the nodular tis-
sues and articular cartilage in the knees and elbows of KO animals. At 12
weeks the knee articular cartilage of KO animals showed an increase in
proteoglycan staining, and a statistically signiﬁcant increase in thick-
ness and chondrocyte cellularity. However, by 36 weeks proteoglycan
staining in KO animals was comparable or worse than controls. Pic-
rosirius red stained knee sections under polarized light also indicated
possible disturbance of superﬁcial articular cartilage extracellular
matrix structure in KO animals as early as 12 weeks of age. Erosion of
bone was observed by both microCT and histology in the knees of KO
animals and appeared to be associated with ligament insertion sites.
TRAP staining was increased surrounding eroded bone sites, and in the
nodular growth and trabeculae of KO animal knees.
Conclusions: The negative regulation of EGFR signalling by Mig-6 in
Col2a1 expressing tissues is important for the maintenance of joint
morphology and homeostasis, and may be involved in regulation of
tissue calciﬁcation. Mig-6 may be a promising molecule for novel
therapeutic interventions for OA and studies evaluating the underlying
causes of cartilage degeneration and joint homeostasis.
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Purpose: MicroRNAs are short endogenous non-coding RNAmolecules,
typically 19-25 nucleotides in length, which negatively regulate gene
expression. In osteoarthritis (OA), several genes necessary for cartilage
homeostasis are aberrantly expressed, with a number of microRNAs
implicated in this process. However, our knowledge of the earliest
stages of OA, prior to the onset of irreversible changes, remains limited.
The purpose of this study was to identifymicroRNAs involved across the
time-course of OA using both a murine model and human cartilage, and
to deﬁne their function.
Methods: Total RNA was puriﬁed from whole knee joints taken from
mice when underwent destabilisation of the medial meniscus (DMM)
